Moreover, the lncRNA LINC p53 induced transcript (LINC-PINT) has been shown to function as an anti-cancer ncRNA in several cancers like GBM, CRC, NSCLC, esophageal cancer, and melanoma (Zhang et al., 2019[64]; Zhu et al., 2021[72]). This evidence concerns the gene LINC-PINT and cancer.